Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003461503 | SCV004199183 | likely pathogenic | Fanconi anemia complementation group G | 2021-12-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003636029 | SCV004538697 | pathogenic | Fanconi anemia | 2023-10-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu232Serfs*2) in the FANCG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCG are known to be pathogenic (PMID: 12552564). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FANCG-related conditions. For these reasons, this variant has been classified as Pathogenic. |